SCHEMBL6418311

SCHEMBL6418311

CC(=O)N1CCN(C(=O)CCN2C(=O)c3ccccc3C(C(=O)NCc3ccco3)C2c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
MAPK1 P28482 1/20 0.47
RECQL P46063 3/20 0.43
HTT P42858 3/20 0.41
TSHR P16473 3/20 0.41
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.40
KDM4E B2RXH2 4/20 0.39
MAPT P10636 2/20 0.39
UBE2M P61081 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
KMT2A Q03164 1/20 0.39
FFAR1 O14842 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6417902 0.93 ALDH1A1 (0.47) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6414870 0.91 ALDH1A1 (0.48) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6418276 0.86 ALDH1A1 (0.54) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6414420 0.86 ALDH1A1 (0.43) ALDH1A1HTTTSHRLMNANPSR1
SCHEMBL6411479 0.86 ALDH1A1 (0.51) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6419057 0.85 ALDH1A1 (0.57) ALDH1A1HTTTSHRLMNAALOX15
SCHEMBL2937775 0.84 ALDH1A1 (0.49) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6413407 0.84 ALDH1A1 (0.66) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6418317 0.84 MAPK1 (0.45) ALDH1A1MAPK1RECQLHTTTSHR
SCHEMBL6416926 0.83 MAPK1 (0.62) ALDH1A1MAPK1RECQLHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US claimed
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed
WO-2004004727-A1 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS AXYS PHARMACEUTICALS, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD ALDH1A1 1368/4885MAPK1 2656/4885RECQL 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.